Human cytomegalovirus replication and of apoptosis in astrocytes

Journal of Human Virology

Volumn 2, Issue 2, 1999, Pages 91-101

  Lokensgard, James R ^a,b   Cheeran, Maxim C J ^a   Gekker, Genya ^a,b   Hu, Shuxian ^a,b   Chao, Chun C ^a,b   Peterson, Phillip K ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Astrocytes; Brain; Human cytomegalovirus; p53

Indexed keywords

APOPTOSIS; ARTICLE; ASTROCYTE; CELL DEATH; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; HUMAN; HUMAN CELL; MICROGLIA; PRIORITY JOURNAL; VIRUS EXPRESSION; VIRUS INFECTION; VIRUS REPLICATION;

ANTIGENS, VIRAL; APOPTOSIS; ASTROCYTES; CELL MEMBRANE; CELL NUCLEUS; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOMEGALOVIRUS; CYTOPATHOGENIC EFFECT, VIRAL; DNA FRAGMENTATION; GENE EXPRESSION REGULATION, VIRAL; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOLOGIC TECHNIQUES; MICROGLIA; NEURONS; TUMOR SUPPRESSOR PROTEIN P53; VIRUS REPLICATION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0033495186     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Kure K, Llena JF, Lyman WD, et al. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric and fetal brains. Hum Pathol 1991;22:700-710.
2. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex. II. Neuropathology. Ann Neurol 1986; 19:525-535.
3. Arribas JR, Storch GA, Clifford DB, Tselis AC. Cytomegalovirus encephalitis. Ann Intern Med 1996;125:577-587.
4. Wiley CA, Schrier RD, Denaro FJ, Nelson JA, Lampert PW, Oldstone MB. Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient. J Neuropathol Exp Neurol 1986;45:127-139.
5. Poland SD, Bambrick LL, Dekaban GA, Rice GP. The extent of human cytomegalovirus replication in primary neurons is dependent on host cell differentiation. J Infect Dis 1994;170:1267-1271.
6. Poland SD, Costello P, Dekaban GA, Rice GP. Cytomegalovirus in the brain: in vitro infection of human brain-derived cells. J Infect Dis 1990;162:1252-1262.
7. Ho WZ, Song L, Douglas SD. Human cytomegalovirus infection and trans-activation of HIV-1 LTR in human brain-derived cells. J Acquir Immune Defic Syndr 1991; 4:1098-1106.
8. Pulliam L. Cytomegalovirus preferentially infects a monocyte derived macrophage/microglial cell in human brain cultures: neuropathology differs between strains. J Neuropathol Exp Neurol 1991;50:432-440.
9. Ibanez CE, Schrier R, Ghazal P, Wiley C, Nelson JA. Human cytomegalovirus productively infects primary differentiated macrophages. J Virol 1991;65:6581-6588.
10. Sinzger C, Plachter B, Grefte A, The TH, Jahn G. Tissue macrophages are infected by human cytomegalovirus in vivo. J Infect Dis 1996;173:240-245.
11. Schut RL, Gekker G, Hu S, et al. Cytomegalovirus replication in murine microglial cell cultures: suppression of permissive infection by interferon-gamma. J Infect Dis 1994;169:1092-1096.
12. Dittmer D, Mocarski ES. Human cytomegalovirus infection inhibits G1/S transition. J Virol 1997;71:1629-1634.
13. Jault FM, Jault JM, Ruchti F, et al. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb and p53, leading to cell cycle arrest. J Virol 1995;69;6697-6704.
14. Lu M, Shenk T. Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S. J Virol 1996;70:8850-8857.
15. Boldogh I, AbuBakar S, Albrecht T. Activation of protooncogenes: an immediate early event in human cytomegalovirus infection. Science 1990;247:561-564.
16. Tsai HL, Kou GH, Chen SC, Wu CW, Lin YS. Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53. J Biol Chem 1996;271:3534-3540.
17. Wing BA, Johnson RA, Huang ES. Identification of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: role of IE2-86 and cellular p53 in mediating negative regulatory function. J Virol 1998;72:1814-1825.
18. Zhu H, Shen Y, Shenk T. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol 1995;69:7960-7970.
19. Peterson PK, Gekker G, Hu S, et al. Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J Neuroimmunol 1994;50:167-175.
20. Chao CC, Gekker G, Hu S, Peterson PK. Human microglial cell defense against Toxoplasma gondii: the role of cytokines. J Immunol 1994;152:1246-1252.
21. Chao CC, Hu S, Sheng WS, Bu D, Bukrinsky MI, Peterson PK. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia 1996;16:276-284.
22. Chao CC, Hu S. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev Neurosci 1994;16:172-179.
23. Bonin LR, McDougall JK. Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function. J Virol 1997;71:5861-5870.
24. Spaete RR, Mocarski ES. Insertion and deletion mutagen-esis of the human cytomegalovirus genome. Proc Natl Acad Sci USA 1987;84:7213-7217.
25. Rimon G, Bazenet CE, Philpott KL, Rubin LL. Increased surface phosphatidylserine is an early marker of neuronal apoptosis. J Neurosci Res 1997;48:563-570.
26. Fadok VA, Savill JS, Haslett C, et al. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992;149:4029-4035.
27. Muganda P, Mendoza O, Hernandez J, Qian Q. Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts. J Virol 1994;68:8028-8034.
28. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994;265:391-394.
29. Kovacs A, Weber ML, Burns LJ, Jacob HS, Vercellotti GM. Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells. Am J Pathol 1996;149: 1531-1539.
30. Drew WL, Mintz L, Hoo R, Finley TN. Growth of herpes simplex and cytomegalovirus in cultured human alveolar macrophages. Am Rev Respir Dis 1979;119:287-291.
31. Pulliam L, Moore D, West DC. Human cytomegalovirus induces IL-6 and TNF-alpha from macrophages and microglial cells: possible role in neurotoxicity. J Neurovirol 1995;1:219-227.
32. McCarthy M, Wood C, Fedoseyeva L, Whittemore SR. Media components influence viral gene expression assays in human fetal astrocyte cultures. J Neurovirol 1995;1:275-285.
33. Muganda P, Carrasco R, Qian Q. The human cytomegalovirus IE2 86 kDa protein elevates p53 levels and transactivates the p53 promoter in human fibroblasts. Cell Mol Biol 1998;44:321-331.
34. Fortunato EA, Spector DH. p53 and Rpa are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus. J Virol 1998;72:2033-2039.
35. Salvant BS, Fortunato EA, Spector DH. Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J Virol 1998;72:3729-3741.
36. Mate JL, Ariza A, Munoz A, Molinero JL, Lopez D, Navas-Palacios JJ. Induction of proliferating cell nuclear antigen and Ki-67 expression by cytomegalovirus infection. J Pathol 1998;184:279-282.
37. Muralidhar S, Doniger J, Mendelson E, et al. Human cytomegalovirus mtrII oncoprotein binds to p53 and downregulates p53-activated transcription. J Virol 1996;70: 8691-8700.
38. Shen Y, Shenk TE. Viruses and apoptosis. Curr Opin Genet Dev 1995;5:105-111.
39. Teodoro JG, Branton PE. Regulation of apoptosis by viral gene products. J Virol 1997;71:1739-1746.
40. Kashanchi F, Araujo J, Doniger J, et al. Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53. Oncogene 1997;14:359-367.
41. Koyama AH, Miwa Y. Suppression of apoptotic DNA fragmentation in herpes simplex virus type 1-infected cells. J Virol 1997;71:2567-2571.
42. Jerome KR, Tait JF, Koelle DM, Corey L. Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis. J Virol 1998;72:436-441.